These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 32784118)

  • 1. Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies.
    Orbach D; Sparber-Sauer M; Laetsch TW; Minard-Colin V; Bielack SS; Casanova M; Corradini N; Koscielniak E; Scheer M; Hettmer S; Bisogno G; Hawkins DS; Ferrari A
    Eur J Cancer; 2020 Sep; 137():183-192. PubMed ID: 32784118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.
    Lemelle L; Guillemot D; Hermann AL; Gauthier A; Carton M; Corradini N; Rome A; Berlanga P; Jourdain A; Marie Cardine A; Jannier S; Boutroux H; Defachelles AS; Aerts I; Geoerger B; Karanian M; Doz F; Brisse HJ; Schleiermacher G; Delattre O; Pierron G; Orbach D
    Expert Rev Anticancer Ther; 2023; 23(8):865-874. PubMed ID: 37434345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic benefit of larotrectinib over the historical standard of care in patients with locally advanced or metastatic infantile fibrosarcoma (EPI VITRAKVI study).
    Orbach D; Carton M; Khadir SK; Feuilly M; Kurtinecz M; Phil D; Vokuhl C; Koscielniak E; Pierron G; Lemelle L; Sparber-Sauer M
    ESMO Open; 2024 May; 9(5):103006. PubMed ID: 38657345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30 Suppl 8():viii31-viii35. PubMed ID: 32223937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience.
    Orbach D; Brennan B; De Paoli A; Gallego S; Mudry P; Francotte N; van Noesel M; Kelsey A; Alaggio R; Ranchère D; De Salvo GL; Casanova M; Bergeron C; Merks JH; Jenney M; Stevens MC; Bisogno G; Ferrari A
    Eur J Cancer; 2016 Apr; 57():1-9. PubMed ID: 26849118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists.
    Klink AJ; Kavati A; Gassama A; Kozlek T; Gajra A; Antoine R
    Target Oncol; 2022 Sep; 17(5):549-561. PubMed ID: 36089643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion.
    Bielack SS; Cox MC; Nathrath M; Apel K; Blattmann C; Holl T; Jenewein R; Klenk U; Klothaki P; Müller-Abt P; Ortega-Lawerenz S; Reynolds M; Scheer M; Simon-Klingenstein K; Stegmaier S; Tupper R; Vokuhl C; von Kalle T
    Ann Oncol; 2019 Nov; 30(Suppl_8):viii31-viii35. PubMed ID: 31738425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A newborn with a large NTRK fusion positive infantile fibrosarcoma successfully treated with larotrectinib.
    Caldwell KJ; De La Cuesta E; Morin C; Pappo A; Helmig S
    Pediatr Blood Cancer; 2020 Sep; 67(9):e28330. PubMed ID: 32452122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic strategies and clinical evolution of patients with infantile fibrosarcoma: a unique paediatric case series.
    Corral Sánchez MD; Jiménez Carrascoso R; Rubio Aparicio P; Plaza López de Sabando D; Sastre Urgelles A; Pozo-Kreilinger JJ; López Gutiérrez JC; Gómez Cervantes M; Ortiz Cruz EJ; Pérez-Martínez A
    Clin Transl Oncol; 2023 Nov; 25(11):3307-3311. PubMed ID: 37097530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infantile fibrosarcoma associated to an abdominal aortic aneurysm with larotrectinib: a case report.
    Corral Sánchez MD; Galán Gómez V; Sastre Urgelles A; Plaza López de Sabando D; Rubio Aparicio P; Martínez Martínez L; Alonso Gamarra E; Pozo Kreilinger JJ; Regojo Zapata RM; López Gutiérrez JC; Antolín Alvarado E; Gómez Martín F; Sánchez Torres AM; Marín Manzano E; González Del Valle L; Pérez-Martínez A
    Pediatr Hematol Oncol; 2021 Aug; 38(5):504-509. PubMed ID: 33622165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile Fibrosarcoma With NTRK3-ETV6 Fusion Successfully Treated With the Tropomyosin-Related Kinase Inhibitor LOXO-101.
    Nagasubramanian R; Wei J; Gordon P; Rastatter JC; Cox MC; Pappo A
    Pediatr Blood Cancer; 2016 Aug; 63(8):1468-70. PubMed ID: 27093299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of current treatment options for NTRK fusion-positive cancers.
    Yang AT; Laetsch TW
    Expert Opin Drug Saf; 2023; 22(11):1073-1089. PubMed ID: 37869783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas.
    DuBois SG; Laetsch TW; Federman N; Turpin BK; Albert CM; Nagasubramanian R; Anderson ME; Davis JL; Qamoos HE; Reynolds ME; Cruickshank S; Cox MC; Hawkins DS; Mascarenhas L; Pappo AS
    Cancer; 2018 Nov; 124(21):4241-4247. PubMed ID: 30204247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of local control in the treatment of children with advanced infantile and adult-type fibrosarcoma: Experience of the cooperative weichteilsarkom studiengruppe (CWS).
    Sparber-Sauer M; Vokuhl C; Seitz G; Stegmaier S; Hallmen E; von Kalle T; Scheer M; Münter M; Bielack SS; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Klingebiel T; Koscielniak E;
    J Pediatr Surg; 2020 Sep; 55(9):1740-1747. PubMed ID: 31753608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of infantile fibrosarcoma with chemotherapy and surgery: results from the Dana-Farber Cancer Institute and Children's Hospital, Boston.
    Loh ML; Ahn P; Perez-Atayde AR; Gebhardt MC; Shamberger RC; Grier HE
    J Pediatr Hematol Oncol; 2002 Dec; 24(9):722-6. PubMed ID: 12468912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy in the management of infantile fibrosarcoma.
    Kynaston JA; Malcolm AJ; Craft AW; Davies SM; Jones PH; King DJ; Mitchell CD; Oakhill A; Stiller CA
    Med Pediatr Oncol; 1993; 21(7):488-93. PubMed ID: 8341216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study.
    Laetsch TW; DuBois SG; Mascarenhas L; Turpin B; Federman N; Albert CM; Nagasubramanian R; Davis JL; Rudzinski E; Feraco AM; Tuch BB; Ebata KT; Reynolds M; Smith S; Cruickshank S; Cox MC; Pappo AS; Hawkins DS
    Lancet Oncol; 2018 May; 19(5):705-714. PubMed ID: 29606586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile fibrosarcoma: management based on the European experience.
    Orbach D; Rey A; Cecchetto G; Oberlin O; Casanova M; Thebaud E; Scopinaro M; Bisogno G; Carli M; Ferrari A
    J Clin Oncol; 2010 Jan; 28(2):318-23. PubMed ID: 19917847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors.
    Dufresne A; Pissaloux D; Ngo C; Penel N; Le Cesne A; Macagno N; Vanacker H; Hénon C; Jean-Denis M; Rughoo K; Tirode F; Blay JY; Brahmi M
    ESMO Open; 2023 Apr; 8(2):101202. PubMed ID: 37054503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.